Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15


Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.

Cunningham EB, Hajarizadeh B, Dalgard O, Amin J, Hellard M, Foster GR, Bruggmann P, Conway B, Backmund M, Robaeys G, Swan T, Marks PS, Quiene S, Applegate TL, Weltman M, Shaw D, Dunlop A, Bruneau J, Midgard H, Bourgeois S, Thurnheer MC, Dore GJ, Grebely J; ACTIVATE Study Group.

BMC Infect Dis. 2017 Jun 13;17(1):420. doi: 10.1186/s12879-017-2517-3.


The Effectiveness of Mobile Phone Text Messaging in Improving Medication Adherence for Patients with Chronic Diseases: A Systematic Review.

Ershad Sarabi R, Sadoughi F, Jamshidi Orak R, Bahaadinbeigy K.

Iran Red Crescent Med J. 2016 Apr 30;18(5):e25183. doi: 10.5812/ircmj.25183. eCollection 2016 May. Review.


A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence.

El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M.

Br J Clin Pharmacol. 2016 Jul;82(1):268-79. doi: 10.1111/bcp.12942. Epub 2016 May 2.


Hepatitis B screening among Chinese Americans: a structural equation modeling analysis.

Ma GX, Zhang GY, Zhai S, Ma X, Tan Y, Shive SE, Wang MQ.

BMC Infect Dis. 2015 Mar 8;15:120. doi: 10.1186/s12879-015-0854-7.


Self-efficacy and adherence to antiviral treatment for chronic hepatitis C.

Bonner JE, Esserman DA, Golin CE, Evon DM.

J Clin Gastroenterol. 2015 Jan;49(1):76-83. doi: 10.1097/MCG.0000000000000055.


Impact of hepatitis C treatment initiation on adherence to concomitant medications.

Pizzirusso M, Lin J, Head C, Marcus SM, Ahmed S, Bräu N, Weiss JJ.

J Assoc Nurses AIDS Care. 2014 Jan-Feb;25(1):23-31. doi: 10.1016/j.jana.2013.07.004. Epub 2013 Sep 24.


Adherence to chronic hepatitis C treatment regimen: first report from a referral center in iran.

Ravi S, Nasiri Toosi M, Karimzadeh I, Ahadi-Barzoki M, Khalili H.

Hepat Mon. 2013 Jun 23;13(6):e11038. doi: 10.5812/hepatmon.11038. eCollection 2013.


Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?

Evon DM, Golin CE, Fried MW, Keefe FJ.

J Consult Clin Psychol. 2013 Apr;81(2):361-74. doi: 10.1037/a0029030. Epub 2012 Jun 25. Review.


Reliability and validity of a self-efficacy instrument for hepatitis C antiviral treatment regimens.

Bonner JE, Esserman D, Evon DM.

J Viral Hepat. 2012 May;19(5):316-26. doi: 10.1111/j.1365-2893.2011.01550.x. Epub 2011 Nov 24.


Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients.

Wagner G, Chan Osilla K, Garnett J, Ghosh-Dastidar B, Bhatti L, Goetz MB, Witt M.

AIDS Res Treat. 2011;2011:903480. doi: 10.1155/2011/903480. Epub 2011 Oct 26.


Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.

Litwin AH, Berg KM, Li X, Hidalgo J, Arnsten JH.

BMC Infect Dis. 2011 Nov 12;11:315. doi: 10.1186/1471-2334-11-315.


Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.

Grebely J, Matthews GV, Hellard M, Shaw D, van Beek I, Petoumenos K, Alavi M, Yeung B, Haber PS, Lloyd AR, Kaldor JM, Dore GJ; ATAHC Study Group.

J Hepatol. 2011 Jul;55(1):76-85. doi: 10.1016/j.jhep.2010.10.033. Epub 2010 Nov 23.


Text messages as a reminder aid and educational tool in adults and adolescents with atopic dermatitis: a pilot study.

Pena-Robichaux V, Kvedar JC, Watson AJ.

Dermatol Res Pract. 2010;2010. pii: 894258. doi: 10.1155/2010/894258. Epub 2010 Sep 1.


Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research.

Weiss JJ, Bräu N, Stivala A, Swan T, Fishbein D.

Aliment Pharmacol Ther. 2009 Jul;30(1):14-27. doi: 10.1111/j.1365-2036.2009.04004.x. Epub 2009 Mar 26. Review.


Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin.

Weiss JJ, Bhatti L, Dieterich DT, Edlin BR, Fishbein DA, Goetz MB, Yu K, Wagner GJ.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):289-93.

Supplemental Content

Support Center